CCDC82 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.202000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.187200E-01
Normal-vs-Stage2
6.313900E-02
Normal-vs-Stage3
1.460180E-01
Normal-vs-Stage4
5.365600E-01
Stage1-vs-Stage2
6.545000E-01
Stage1-vs-Stage3
5.620600E-01
Stage1-vs-Stage4
7.781600E-01
Stage2-vs-Stage3
6.432800E-01
Stage2-vs-Stage4
4.048200E-01
Stage3-vs-Stage4
4.503200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.647900E-02
Normal-vs-AfricanAmerican
1.591760E-01
Normal-vs-Asian
7.630500E-02
Caucasian-vs-AfricanAmerican
8.150600E-01
Caucasian-vs-Asian
3.648400E-01
AfricanAmerican-vs-Asian
4.480200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.036400E-02
Normal-vs-Female
1.136250E-01
Male-vs-Female
1.027360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.699780E-01
Normal-vs-Age(41-60Yrs)
1.002360E-01
Normal-vs-Age(61-80Yrs)
7.066400E-02
Normal-vs-Age(81-100Yrs)
1.802040E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.925400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.608800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.744400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.025600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.364000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.631800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.944000E-02
Normal-vs-Daily Drinker
1.525940E-02
Normal-vs-Weekly Drinker
5.409700E-02
Normal-vs-Occasional Drinker
6.704500E-02
Normal-vs-Social Drinker
7.117900E-02
Non Drinker-vs-Daily Drinker
2.880600E-01
Non Drinker-vs-Weekly Drinker
8.865800E-01
Non Drinker-vs-Occasional Drinker
6.175800E-01
Non Drinker-vs-Social Drinker
7.862800E-01
Daily Drinker-vs-Weekly Drinker
4.716000E-01
Daily Drinker-vs-Occasional Drinker
1.668220E-01
Daily Drinker-vs-Social Drinker
2.641800E-01
Weekly Drinker-vs-Occasional Drinker
5.928200E-01
Weekly Drinker-vs-Social Drinker
7.319800E-01
Occasional Drinker-vs-Social Drinker
8.617600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.207900E-02
Normal-vs-Grade 2
3.338500E-03
Normal-vs-Grade 3
2.035700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.092500E-02
Grade 1-vs-Grade 3
1.048040E-01
Grade 1-vs-Grade 4
8.207900E-02
Grade 2-vs-Grade 3
7.898600E-01
Grade 2-vs-Grade 4
3.338500E-03
Grade 3-vs-Grade 4
2.035700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.430470E-02
Normal-vs-NonDiabetic
3.757800E-02
Diabetic-vs-NonDiabetic
1.922230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.021500E-02
Normal-vs-NoPancreatitis
2.125700E-02
Pancreatitis-vs-NoPancreatitis
7.081400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.028240E-01
Normal-vs-N1
5.981900E-02
N0-vs-N1
7.072600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.367250E-01
Normal-vs-TP53-NonMutant
6.234000E-02
TP53-Mutant-vs-TP53-NonMutant
1.775830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
